The BMJ Today: Sugar, HRT, and a neonate with a rash

juliet_dobson• There are a number of responses to The BMJ’s latest investigation into links between public health scientists and food companies. Michelle Harvie and Louise Gorman say, “Industry funding is an inevitable consequence of limited government research funds. In addition it is useful for academia to link with industry as this allows research findings to be more rapidly translated into products and interventions.”

• Women who take hormone replacement therapy (HRT) even for a few years are 40% more likely to develop two of the most common types of ovarian cancer than women who have never taken HRT, according to an analysis of 52 epidemiological studies involving a total of 21 488 women.


• This week’s Minerva picture shows a 3 week old neonate with an annular erythematous rash on her face (see photo). She had thrombocytopenia, and raised liver enzymes. Her rash was initially treated as an infection but was subsequently diagnosed as neonatal lupus erythematosus (NLE).

Sarah Jones et al lament the lack of action on behalf of the UK government to reduce deaths and injuries associated with young drivers.

• Chronic pain is one of the most common conditions encountered by healthcare professionals, particularly among patients older than 65 years. Our most recent clinical review summarises recent evidence on the assessment and management of pain in older patients.

Juliet Dobson is web editor and blogs editor, The BMJ.